CURRICULUM VITAE
`Lawrence R. Poree
`University of California at San Francisco
`Department of Anesthesia, Pain Management Center
`
`EDUCATION
`2001-2002 Pain Fellowship, University of California at San Francisco, San Francisco, CA
` 1998-2001 Anesthesia Residency, Stanford University Medical Center, Stanford, CA.
` 1997-1998 Transitional Internship; Santa Clara Valley Medical Center, San Jose, CA
` 1993-1997 M.D.; Stanford University School of Medicine
` 1988-1989 Postdoctoral Fellowship in Biomedical Engineering and Neuroscience: The
`
`
`Johns Hopkins University School of Medicine
` 1985-1988 Ph.D. Toxicology/Environmental Health Sciences; University of California
` 1983-1984 M.P.H. Toxicology/Environmental Health Sciences; University of California
` 1977-1981 B.A. Pharmacology: University of California at Santa Barbara
`
`
`BOARD CERTIFICATIONS
`American Board of Anesthesiology with certification in Pain Management; Board Certified
`American Academy of Pain Medicine; Board Certified
`
`
`
`
`
`POSITIONS
` 2015-present: Clinical Professor and Director of Neuromodulation Service, Department of
`
` Anesthesia, University of California at San Francisco
` 2017-present: Board of Directors for the International Neuromodulation Society
` 2017-present: Counsel Member for Institute of Neuromodulation
` 2012-present: Board of Directors for the California Society of Interventional Pain Physicians
` 2013-2014: Editor of North American Neuromodulation Society Newsletter
` 2011-present: Board of Directors for the North American Neuromodulation Society
` 2011-2014: Volunteer Associate Professor, Department of Anesthesia; UCSF
` 2002-2011: Volunteer Instructor and Assistant Professor, Department of Anesthesia; UCSF
` 2002-2014: Private Practice: Pain Clinic of Monterey Bay, Aptos, California
`
`
`EDITORIAL BOARDS
` 2009-2010 editorial board for journal Pain
` 2008-present editorial board for journal Neuromodulation
`
`
`CURRENT RESEARCH PROJECT
`
` 2017- present A Post-Approval Study to Evaluate Targeted SCS (DRG) Stimulation for the
`Management of Moderate to Severe Chronic, Intractable, Pain of the Lower Limbs due to
`CRPS types I and II (TARGET)
` 2013- 2016 Randomized Controlled Study of Spinal Cord Stimulation vs DRG stimulation in
` the treatment of Lower Extremity Neuropathic Pain.
` 2011-2013 Levorphanol Opioid Titration Study
`
`
`SOCIETY MEMBERSHIP
` 2001-2015 International Spinal Injection Society
` 2001-present American Academy of Pain Medicine
` 2003-present American Society of Interventional Pain Physicians
` 2011-present California Society of Interventional Pain Physicians
` 2003-present North American Neuromodulation Society
`
`
`
`
`
`
`
`1
`
`Grun. Exh. 1004
`PGR for U.S. Patent No. 9,867,839
`
`Grün. Exh. 1005
`PGR for U.S. Patent No. 10,052,338
`
`

`

` 2003-present International Neuromodulation Society
`
`
`INVITED LECTURES
`
`
`
`2018: North American Neuromodulation Society Annual Meeting; Quality and Clinical Responses
`in Sleep with a New, Closed-Loop Spinal Cord Stimulation System
`2017: Neuromodulation Society of the UK & Ireland, Oxford, UK Selection of Neuromodulation
`Devices
`2017: Neuromodulation Society of the UK & Ireland, Oxford, UK Closed loop SCS: 12 month
`data from Avalon study
`2017: German Neuromodulation Society meeting; Düsseldorf, Closed loop SCS: 12 month data
`from Avalon study
`2017: UCSF Pain Research Group: Clinical trials of DRG stimulation. San Francisco, CA
`2017: UCSF Anesthesiology Grand Rounds: Perioperative management of intrathecal pumps
`
` San Francisco, CA
`2017: North American Neuromodulation Society: DRG Accurate Study sub study, Las Vegas, NV
`2016: California Society of Interventional Pain Physicians: Advances in Neuromodulation,
` Santa Barbara, CA
`2016: International Association of Pain: Pathophysiology of DRG stimulation, Yokohama, Japan
`2016: UCSF Post Graduate Surgery Conference: Neuromodulation for the treatment of post
`
` hernia surgery pain, San Francisco, CA
`2016: Neural Interface Conference: Intrathecal Therapy for Pain: An Alternative to Systemic
`
` Opioids. Baltimore, MD
`2016: Kauai Pain Meeting: Neuromodulation advances in pain management, Lihue, HI
`2016: Kauai Pain Meeting: Neuromodulation to treat post hernia surgery pain, Lihue, HI
`2016: Neuromodulation Society of Australia and New Zealand: Neuromodulation vs Surgery,
` Perth, Australia
`2016: Neuromodulation Society of Australia and New Zealand: NIH neuromodulation studies
`
` Perth, Australia
`2016: Osher Mini Medical School lecture: Neuromodulation for pain control, San Francisco, CA
`2016: Avamed conference: Technology versus Pain: Targeted Drug Delivery and Electrical
` Stimulation Alternatives to Systemic Opioids, Minneapolis, MN
`2016: Seattle Science Foundation Interventional Pain Management Fellows Course: Implant
`
` techniques for spinal cord and DRG stimulation, Seattle, WA
`2015: North American Neuromodulation Society: Advances in Intrathecal Therapy, Las Vegas, NV
`2015: North American Neuromodulation Society Wired vs Wireless Neuromodulation Technology
`
` Las Vegas, NV
`2015: California Society of Interventional Pain Physicians: Advances in Neuromodulation,
` Monterey, CA
`2015: Conference on The Changing Practice of Anesthesia: Advances in Neuromodulation,
` San Francisco, CA
`2015: International Neuromodulation Society: Continuity of Care in Intrathecal Drug Delivery,
` Montreal, Canada
`2015: San Francisco Neurological Society, Monterey CA: Selection Criteria for Spinal Cord
` Stimulation, Monterey, CA
`2015: Hawaii Pain Meeting: Safe Prescribing: Opioids for Pain in 2015, Lihue, HI
`2015: Hawaii Pain Meeting: Targeted Drug Delivery in 2015, Lihue, HI
`2015: UCSF Grand Rounds: Evidence for the use of Intrathecal Therapy for Chronic Pain
`
` San Francisco, CA
`2014: Swiss Neuromodulation Society: Management of Patients with Intrathecal Pumps in
`
` Various Clinical Settings; Montreux Switzerland
`
`2
`
`

`

`2014: Napa Pain Conference: Pharmacokinetics of Intrathecal therapy; Napa, CA
`2014: Napa Pain Conference: Cryotherapy, a novel treatment for knee pain; Napa, CA
`2014: Napa Pain Conference: New Horizons in Intrathecal therapy, Napa, CA
` 2014: Michigan State Medical School Grand Rounds: Advances in the Neuromodulation of Pain
` Lansing, MI
` 2013: North American Neuromodulation Society: Intrathecal Therapy, What is Under the Hood
`
` Las Vegas, NV
` 2013: North American Neuromodulation Society: Past Present and Future of Intrathecal Therapy
`
` Las Vegas, NV
` 2013: UCSF Pain Grand Rounds: Targeted Analgesia with Neuromodulation, San Francisco, CA
` 2013: Congress of Neurological Surgeons: Emerging Technologies of Neuromodulation for pain
`
` San Francisco, CA
` 2012: California Society of Interventional Pain Physicians: DRG Neuromodulation,
` New Port Beach, CA
` 2012: Dominican Hospital Conference peri-operative pain management. Santa Cruz, CA
` 2010: Santa Cruz County Health Services: Update on Risk evaluation and management
` of opioid therapy. Santa Cruz, CA
` 2010 Australian Chapter of the International Neuromodulation Society: Dorsal Root
` Ganglion Stimulation: a Novel Target for Neuromodulation, New Castle, Australia
` 2009: Society of Urological Nurses Associates; Interdisciplinary care of patients with pelvic pain
`
` San Francisco, CA
` 2008: Napa Pain Conference: S.A.F.E. Principles Used to Develop Algorithms Using Spinal Cord
`
` Stimulation. Napa CA
` 2008: California Society of Physical Medicine and Rehabilitation Annual Meeting.
` Topic: Advances in Neuromodulation Therapy, Las Vegas, NV
` 2006: Conference on The Changing Practice of Anesthesia.
` Topic: Advances in the treatment of Neuropathic Pain. San Francisco, CA
` 2005: Grand Rounds at Dominican Hospital. Topic: Neuromodulation in the treatment of
` Peripheral Vascular Disease and Angina, Santa Cruz, C
` 2003-2004 : Program director and lecturer for 12 hour course on Pain Management and
` End of Life Care sponsored by the Santa Cruz Medical Society, Santa Cruz Health
` Department, Dominican Hospital, and Watsonville Hospital. Scotts Valley, CA
`
`PUBLICATIONS
`
`
`
`
`Noon,K, Poree, LR, Ike, K, Jones II, JC: Intrathecal Pump Malfunction: Flipped, Expired, Stalled, and
`Malfunctioned Valves and Rotors Leading to Under and Over-Infusion, Chapter 29 in Challenging Cases and
`Complication Management in Pain Medicine 1st ed. 2018 Edition by Magdalena Anitescu (Editor), Honorio
`T. Benzon (Editor), Mark S. Wallace (Editor) Publisher Spriger
`
`
`
`Peniche, A., Poree, L., Schumacher, M., Yu, X. (in press). Integrating Patient-Controlled Analgesia Using
`Implanted IT Pumps for Postoperative Pain Management. A& A Case Reports. May 2018
`
`Russo M, Cousins MJ, Brooker C, Taylor N, Boesel T, Sullivan R, Poree L, Shariati NH, Hanson E, Parker
`Effective Relief of Pain and Associated Symptoms With Closed-Loop Spinal Cord Stimulation System:
`Preliminary Results of the Avalon Study. J. Neuromodulation. 2017 Sep 18.
`
`
`
` Southwell DG, Osorio JA, Liverman CS, Friedman LM, Naidu RK, Poree LR, Henry MM, Jacques L
`
`3
`
`

`

`Intrathecal catheter-associated inflammatory mass in a neurofibromatosis type-1 patient receiving fentanyl
`and bupivacaine. Surg Neurol Int. 2017 Jul 25;8:159
`
`Amirdelfan K, Webster L, Poree L, Sukul V, McRoberts P.Treatment Options for Failed Back Surgery
`Syndrome (FBSS) Patients with Refractory Chronic Pain: An Evidence-Based Approach. Spine; 2017 Jul
`15;42 Suppl 14:S41-S52
`
`Deer TR, Levy RM, Kramer J, Poree L, Amirdelfan K, Grigsby E, Staats P, Burton AW, Burgher AH, Obray
`J, Scowcroft J, Golovac S, Kapural L, Paicius R, Kim C, Pope J, Yearwood T, Samuel S, McRoberts WP,
`Cassim H, Netherton M, Miller N, Schaufele M, Tavel E, Davis T, Davis K, Johnson L, Mekhail N. Dorsal
`root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and
`causalgia at 3 and 12 months: a randomized comparative trial. Pain. 2017 Apr;158(4):669-
`
`
`Deer TR, Pope JE, Hayek SM, Bux A, Buchser E, Eldabe S, De Andrés JA, Erdek M, Patin D, Grider JS,
`Doleys DM, Jacobs MS, Yaksh TL, Poree L, Wallace MS, Prager J, Rauck R, DeLeon O, Diwan S, Falowski
`SM, Gazelka HM, Kim P, Leong M, Levy RM, McDowell Ii G, McRoberts P, Naidu R, Narouze S,
`Perruchoud C, Rosen SM, Rosenberg WS, Saulino M, Staats P, Stearns LJ, Willis D, Krames E, Huntoon M,
`Mekhail N. The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug
`Infusion Systems Best Practices and Guidelines. Neuromodulation. 2017 Feb;20(2):96-132
`
`
`
`Pope J, McRoberts WP, Deer T, Poree L. Are Bolus Dosing Strategies the Intrathecal Version of Novel
`Waveforms With Spinal Cord Stimulation? Neuromodulation. 2015 Dec;18(8):776-7.
`
`
`
`Pope J, Poree L, McRoberts WP, Falowski S, Deer T.: Consent Decree: Physician and Institution
`Ramifications?Neuromodulation. 2015 Dec;18(8):653-6.
`
`
`
`
`
`Deer T.R., Mekhail N., Provenzano D., Pope J., Krames E., Leong M., Levy R.M., Abejon D., Buchser E.,
`Burton A., Buvanendran A., Candido K., Caraway D., Cousins M., DeJongste M., Diwan S., Eldabe S.,
`Gatzinsky K., Foreman R.D., Hayek S., Kim P., Kinfe T., Kloth D., Kumar
`K., Rizvi S., Lad S.P., Liem L., Linderoth B., Mackey S., McDowell G., McRoberts P., Poree L., Prager J.,
`Raso L., Rauck R., Russo M., Simpson B., Slavin K., Staats P., Stanton-Hicks M., Verrills P., Wellington J.,
`Williams K., North R. The Appropriate Use of Neurostimulation of the Spinal Cord and Peripheral Nervous
`System for the Treatment of Chronic Pain and Ischemic Diseases: The Neuromodulation Appropriateness
`Consensus Committee. Neuromodulation 2014; 17: 515–550.
`
`Deer, T. R., Mekhail, N., Provenzano, D., Pope, J., Krames, E., Thomson, S., Raso, L., Burton, A.,
`DeAndres, J., Buchser, E., Buvanendran, A., Liem, L., Kumar, K., Rizvi, S., Feler, C., Abejon, D.,
`Anderson, J., Eldabe, S., Kim, P., Leong, M., Hayek, S., McDowell, G., Poree, L., Brooks, E. S., McJunkin,
`T., Lynch, P., Kapural, L., Foreman, R. D., Caraway, D., Alo, K., Narouze, S., Levy, R. M. and North,
`R. The Appropriate Use of Neurostimulation: Avoidance and Treatment of Complications of
`Neurostimulation Therapies for the Treatment of Chronic Pain. Neuromodulation 2014; 17: 571–598.
`
`Deer, T. R., Krames, E., Mekhail, N., Pope, J., Leong, M., Stanton-Hicks, M., Golovac, S., Kapural, L., Alo,
`K., Anderson, J., Foreman, R. D., Caraway, D., Narouze, S., Linderoth, B., Buvanendran, A., Feler, C.,
`Poree, L., Lynch, P., McJunkin, T., Swing, T., Staats, P., Liem, L. and Williams, K. (2014), The Appropriate
`Use of Neurostimulation: New and Evolving Neurostimulation Therapies and Applicable Treatment for
`Chronic Pain and Selected Disease States. Neuromodulation: 2014; 17: 599–615.
`
`4
`
`

`

`
`Epidural Hematomas Following Removal of Percutaneous Spinal Cord Stimulator Trial Leads: Two Case
`Reports; Giberson,C; Barbosa,J; Brooks, E; McGlothlen, G; Grigsby, E; Kohut, J; Wolbers, L; Poree, L.;
`2013 Regional Anesthesia and Pain Medicine • Volume 39, Number 1, 2014
`
`Poree,L; Krames,E; Pope, J; Deer, T; Levy,R; Dhillon,V; Shultz, L: Spinal Cord Stimulation as treatment for
`Complex Regional Pain Syndrome Should be Considered Earlier than Last Resort Therapy
`Neuromodulation 2012.
`
`
`Poree, L; Wolbers,L: Spinal Targets for interventional Pain Management: in AAPM Textbook of Pain
`Medicine; ed: Deer, T. and Leong, M.: 2012;
`
`Krames, Elliot S.; Monis, Sayed; Poree, Lawrence; Deer, Timothy; Levy, Robert : Using the SAFE
`Principles When Evaluating Electrical Stimulation Therapies For the Pain of Failed Back Surgery
`Syndrome Neuromodulation: 2011 July/August issue, Volume 14, Number 4
`
`Henderson, Jaimie.; Levy, Robert ; Bedder, Marshall ; Staats, Peter; Slavin, Konstantin; Poree, Lawrence ;
`North, Richard NANS Training Requirements for Spinal Cord Stimulation Devices: Selection, Implantation,
`and Follow-up.: Neuromodulation 2009 vol 12:3(p 171-174)
`
`Krames, E., Poree, L.R., Deer, T., Levy, R: Implementing the SAFE Principles for the Development of Pain
`Medicine Therapeutic Algorithms That Include Neuromodulation Techniques
`Neuromodulation 2009 vol 12:2(p 104-113)
`
`Krames, E., Poree, L., Deer, T., Levy, R: Editorial: Neuromodulation for pain management:
`Pain Medicine Vol. 10:1, 1-5, 2009
`
`Poree, L.R., Guo, T.Z., Kingery, W.S., Maze, M.: The analgesic potency of dexmedetomidine is enhanced
`after nerve injury: a possible role for peripheral alpha2-adrenoceptors. Anesth Analg. 87(4): 941-948,
`1998
`
`Kingery, W.S., Guo, T.Z., Poree, L.P., Maze, L.P.: Colchicine treatment of the sciatic nerve reduces
`neurogenic extravasation, but does not affect nociceptive thresholds or collateral sprouting in neuropathic or
`normal rats. Pain 74(1): 11-20, 1998
`
`Guo, T.Z., Poree,L., Golden, W., Fujinaga,M., Maze,M.: The antinociceptive response to nitrous oxide is
`medaited by supraspinal opiate and spinal (cid:1)2 adrenergic recetpors in the rat. Anesthesiology, 85(4): 846-
`852, 1996
`
`Poree, L.R. and Schramm, L.P. Role of cervical neurons in propriospinal inhibition of thoracic dorsal horn
`neurons. Brain.Res. 599:302-308, 1992.
`
`Poree, L.R. and Schramm, L.P. Interaction between medullary and cervical regulation of renal sympathetic
`activity. Brain.Res. 599:297-301, 1992.
`
` Schramm, L.P., and Poree, L.R.: Medullo-spinal modulation of sympathetic output and spinal afferent input.
`J. Cardiovascular Electrophysiology Supp. 2:S18-S25, 1991
`
`Poree,L.P., Dickenson, A.H., and Wei, E.T.: Corticotropin-releasing factor inhibits the response of
`trigeminal neurons to noxious heat. Brain Res. 502:349-355, 1989
`
`
`5
`
`

`

`Poree,L.P., Dickenson, A.H., and Wei, E.T.: Corticotropin-releasing factor inhibits the response of
`trigeminal neurons to noxious heat. Brain Res. 502:349-355, 1989
`
`Kiang, J.G., Poree, L.R., and Wei, E.T.: Anti-inflammatory activity of corticotropin-releasing factor: II.
`Mechanisms of action. Proc. West. Pharmacol. Soc. 30:63-65, 1987
`
`
`ABSTRACTS
`
`
`Effective Relief of Pain and Associated Symptoms with a New Closed-loop Spinal Cord Stimulation System.
`Marc Russo, MD, Michael Cousins, MD, Charles Brooker, MD, Richard Sullivan, MD, Tilman Boesel, MD,
`Nathan Taylor, MD, Rebecca Martin, MD, Martine O'Neill, MD, Lawrence Poree, MD, Erin Hanson, MPH,
`John Parker, PhD: International Neuromodulation Society Meeting, Edinburgh UK 2017
`
`Closed-Loop Spinal Cord Stimulation – A Novel Stimulation Paradigm to Mitigate Tolerance?
`Marc Russo, MD, Michael Cousins, MD, Charles Brooker, MD, Richard Sullivan, MD, Tilman Boesel, MD,
`Nathan Taylor, MD, Rebecca Martin, MD, Martine O'Neill, MD, Lawrence Poree, MD, Nicole Soliday,
`MPH, John Parker, PhD: International Neuromodulation Society Meeting, Edinburgh UK 2017
`
`Managing Electrical Interference with Neuromodulation Devices in the Operating Room;
`1
`
`Prasad Shirvalkar MD, PhD
`1
`
`, Lawrence Poree MD, PHD, MPH North American Neuromodulation Society
`
`
`
`Meeting, Las Vegas, 2017
`
`High frequency 10 kHz spinal cord stimulation used to treat refractory, chronic pancreatitis pain
` Keeley Dohmeier, MD, William S. Rosenberg, MD, Lawrence Poree, MD, PhD
`University of California San Francisco, San Francisco, CA, Center for the Relief of Pain, Kansas City, MO
`1
`
`North American Neuromodulation Society Meeting, Las Vegas, 2017
`
`
`HF10 salvage using in situ electrodes from traditional paresthesia-based manufactures: a case series
`Christopher. R. Abrecht, MD, William S. Rosenberg, MD, Lawrence Poree, MD, PhD;University of
`California San Francisco, San Francisco, CA, Center for the Relief of Pain, Kansas City, MO North
`1
`
`
`
`American Neuromodulation Society Meeting, Las Vegas, 2017
`
`Psychological preparation and intraoperative intervention: Treating emotional trauma before spinal cord
`stimulator implant to avoid use of general anesthesia; Deepali Dhar, MD; Jessica E Pullins, PhD; Thoha M
`Pham, MD; Lawrence Poree, MD PhD; University of California San Francisco, San Francisco, CA, North
`1
`
`
`
`
`
`American Neuromodulation Society Meeting, Las Vegas, 2017
`
`DRG Stimulation Salvage for Failed SCS in Patients with CRPS: Ann Cai Shah, MD; Ramana Naidu, MD;
`Lawrence Poree, MD, PhD; University of California San Francisco, San Francisco, CA, North American
`Neuromodulation Society Meeting, Las Vegas, 2017
`
`Integrating Intrathecal Pump Patient Activator into Postoperative Pain Management: Lessons and
`Challenges. Peniche A, Higgins E, Lieberman J, Brynelson S, Schumacher M, Ames C, Poree L, Yu X;
`University of California San Francisco, San Francisco, CA, North American Neuromodulation Society
`Meeting, Las Vegas, 2017
`
`Spinal Cord Stimulation Trial Complicated by C. difficile Associated Diarrhea, and Use of Probiotics to
`Reduce Antibiotic Associated C. difficile Infections. Heidi Reetz, MD; Lawrence Poree, MD
`
`6
`
`

`

`Pain Management, Department of Anesthesia, University of California, San Francisco. NANS 2015
`
`Implantable Pumps Used For Nerve Root Sleeve Infusions: Can The S.A.F.E. Principles Be Applied to
`Improve Outcomes? E. Ezeji-Okoye*; L. Wolbers, MD, MPH; L. Poree@, MD, MPH, PhD
` NANS 2015
`
`Intrathecal Granuloma in Patient Receiving Intrathecal Fentanyl and Bupivacaine
`Lauren Friedman, MD; Ramana Naidu, MD; Lawrence Poree, MD, PhD; Line Jacques, MD; Melanie Henry,
`MD, MPH; Derek Southwell, MD, PhD Department of Anesthesia and Perioperative Care and Neurosurgery,
`University of California, San Francisco. NANS 2015
`
`Good Intentions Gone Bad: Case Study of a Patient Accessing an Intrathecal Pump; Wajde Dabah, MD;
`Lawrence Poree, MD, MPH, PhD; Jessica Pullins, PhD; Department of Anesthesia and Perioperative Care,
`University of California San Francisco NANS, 2015
`
`Timothy Deer MD, Robert Levy MD PhD, Eric Grigsby MD, Kasra Amirdelfan MD, Lawrence Poree MD,
`Peter Staats MD, David Caraway MD, Nagy Mekhail MD PhD, Jeffery Kramer PhD; A prospective,
`randomized, multi-center, controlled clinical trial to assess the safety and efficacy of the Spinal Modulation
`Axium® Neurostimulation System in the treatment of chronic pain (ACCURATE Trial): Trial Design;
`NANS 2014
`
`Poree, L; Quinn, R.; Wolbers, L; Rawlings, J: Baclofen and Clonidine Withdrawal in Two Patients Due to
`Mismanagement of Intrathecal Pumps: Two Case Studies that Support the Need For Improved Intrathecal
`Pump Training Guidelines. NANS 2013
`
`Intrathecal Granulomas in Two Patients with Low Dose Medications: Is There a Role for Routine
`Monitoring of CSF Protein? Kenneth Ike, MD; Elizabeth Brooks, PhD; Linda Wolbers, MD, MPH;
`Lawrence Poree, MD, MPH, PhD Stanford University, Stanford, CA; Pain Clinic of Monterey Bay, Aptos,
`CA; 3. University of California at San Francisco NANS 2013
`
`
`Giberson, C; Barbosa, J. ; Wolbers, L.; Henderson, J; Poree, L: Case Report: Epidural Hematoma After
`Removal of Percutaneous SCS Trial Leads 2012 North American Neuromodulation Society
`
`Poree, Lawrence R. Anatomy, Pathophysiology, and Neuromodulation of the Dorsal Root Ganglion-Why
`You Should Care; Australian Neuromodulation Society; Neuromodulation 2011;14:89-91
`
`Poree, LR; Krames, E. : Use of anatomical and biochemical techniques to confirm intrathecal catheterization:
`A case report. International Neuromodulation Conference 2007.
`
`Angst,M.S.; Poree,L.R.; Ramaswamy,B.: Reliable quantification of opioid analgesia with a new
`experimental pain model in man. Clinical Pharmacology & Therapeutics 61(2):III1, 1997
`
`Poree LR, Angst MS, Dyck JB. Evaluation of a new experimental electrical pain model in humans. 8th
`World Congress on Pain, Vancouver, Canada. International Association for the Study of Pain Press, Seattle,
`Washington, 1996;Abstracts page 332(5).
`
`Angst MS, Poree LR, Dyck JB. Evaluation of sequential, centering and spacing bias in a new experimental
`pain model in humans. International Association for the Study of Pain Press, Seattle, Washington
`1996;Abstracts page 332(6).
`
`Kingery, W.S., Poree,L.R., Guo, T.Z., Maze, M.: Colchine treatment of the sciatic nerve causes a prolonged
`reduction of neurogenic extravasation, but does not affect saphenous mediated nociceptive thresholds,
`
`7
`
`

`

`autotomy behavior, or saphenous collateral sprouting in normal or sciatic transected rats. International
`Association for the Study of Pain 8:27, 1996
`
`Maze, M., Kingery, W.S., Guo, T.Z., Macmillan, L., Limbird, L., Poree,L.R.: Tibial sectioned mice become
`insensitive to the analgesic but not the sedative effects of dexmedetomidine, and can develop a neuropathic
`hyeralgesia independent of (cid:1)2-A receptor function. International Association for the Study of Pain 8:348,
`1996
`
`Angst, M.S., Poree, L.R., Dyck, J.B.: Evaluation of sequential, centering and spacing bias in a new
`experimental pain model in humans. International Association for the Study of Pain 8:332, 1996
`
`Poree, L.R., Angst,M.S., Dyck, J.B.: Evaluation of a new experimental electrical pain model in humans.
`International Association for the Study of Pain 8: 332, 1996
`
`Poree, L.R., Guo, K.; Limbird, L.; Maze, M: Dexmedetomidine inhibits nociception in wild type but not
`transgenic mice with alpha-2A adrenoceptors uncoupled from potassium channels. American Pain Society
`meeting, 1995
`
`Poree, L.R.; Guo, K.; Kingery, W.; Maze, M: Analgesic actions of dexmedetomidine in an animal model of
`neuropathic pain: Society for Neuroscience Abstracts 20: 305, 1994
`
` Poree, L.R. and Schramm, L. P.: Role of thoracic interneurons in cervically-evoked sympathoinhibition in
`the rat. Society for Neuroscience Abstracts 16:216, 1990
`
`Poree, L.R. and Schramm, L. P.: Bilateral injection of muscimol into the rat rostral ventrolateral medulla
`fails to decrease mean renal nerve activity. Society for Neuroscience Abstracts 15:592, 1989
`
`Poree, L.R., Dickenson, A.H., and Wei, E.T.: Corticotropin-releasing factor inhibits trigeminal nociceptive
`neurons. The Pharmacologist 29:129, 1987.
`
`Poree, L.R. and Wei, E.T.: Evidence for peripheral inhibitory actions of an enkephalin analog on trigeminal
`nociceptive neurons. International Narcotics Research Conference, 18:176, 1987
`
`
`8
`
`